Literature DB >> 12599061

Immunoglobulin G (IgG) responses to Plasmodium falciparum glycosylphosphatidylinositols are short-lived and predominantly of the IgG3 subclass.

Craig S Boutlis1, Peter K Fagan, D Channe Gowda, Moses Lagog, Charles S Mgone, Moses J Bockarie, Nicholas M Anstey.   

Abstract

The induction of neutralizing immunity to Plasmodium falciparum toxins by vaccination has been proposed as a preventive strategy to limit the severity of malaria. For this approach to be successful, generation of a sustained immune response would be necessary. This study shows that immunoglobulin G (IgG)-subclass responses elicited by the proposed P. falciparum toxin glycosylphosphatidylinositol (GPI) in Papua New Guinean subjects 5-60 years old predominantly involve IgG(3), with a lesser contribution from IgG(1) and an absence of IgG(2) and IgG(4). IgG(3) levels declined sharply within 6 weeks of pharmacological clearance of parasitemia in all subjects, whereas a significant decrease in IgG(1) levels was seen only in subjects < or =19 years old. Because the natural antibody response to P. falciparum GPIs is skewed toward the short-lived IgG(3) subclass, a vaccination strategy with GPI analogues would likely require augmentation by costimulatory molecules, to induce a more persistent anti-GPI response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12599061     DOI: 10.1086/367897

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  Immunoglobulin G isotype responses to variant surface antigens of Plasmodium falciparum in healthy Gabonese adults and children during and after successive malaria attacks.

Authors:  Gerardo Cabrera; Clarisse Yone; Anne E Tebo; Jan van Aaken; Bertrand Lell; Peter G Kremsner; Adrian J F Luty
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

2.  Target antigen, age, and duration of antigen exposure independently regulate immunoglobulin G subclass switching in malaria.

Authors:  J Eric Tongren; Christopher J Drakeley; Suzanna L R McDonald; Hugh G Reyburn; Alphaxard Manjurano; Watoky M M Nkya; Martha M Lemnge; Channe D Gowda; Jim E Todd; Patrick H Corran; Eleanor M Riley
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  Serum antibody levels to glycosylphosphatidylinositols in specimens derived from matched Malian children with severe or uncomplicated Plasmodium falciparum malaria and healthy controls.

Authors:  Yacouba Cissoko; Modibo Daou; Kirsten E Lyke; Alassane Dicko; Issa Diarra; Abdoulaye Kone; Ando Guindo; Karim Traore; Gowdahalli Krishnegowda; Dapa A Diallo; Ogobara K Doumbo; Christopher V Plowe; D Channe Gowda; Marcelo B Sztein
Journal:  Am J Trop Med Hyg       Date:  2006-08       Impact factor: 2.345

Review 4.  Malaria tolerance--for whom the cell tolls?

Authors:  Craig S Boutlis; Tsin W Yeo; Nicholas M Anstey
Journal:  Trends Parasitol       Date:  2006-06-19

5.  Neutralization of malaria glycosylphosphatidylinositol in vitro by serum IgG from malaria-exposed individuals.

Authors:  J Brian de Souza; Manohursingh Runglall; Patrick H Corran; Lucy C Okell; Sanjeev Kumar; D Channe Gowda; Kevin N Couper; Eleanor M Riley
Journal:  Infect Immun       Date:  2010-06-21       Impact factor: 3.441

6.  CD28 costimulation is required for the expression of T-cell-dependent cell-mediated immunity against blood-stage Plasmodium chabaudi malaria parasites.

Authors:  Thomas Rummel; Joan Batchelder; Patrick Flaherty; GayeLyn LaFleur; Payal Nanavati; James M Burns; William P Weidanz
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

7.  Lack of an association between antibodies to Plasmodium falciparum glycosylphosphatidylinositols and malaria-associated placental changes in Cameroonian women with preterm and full-term deliveries.

Authors:  Amorsolo L Suguitan; D Channe Gowda; Genevieve Fouda; Lucy Thuita; Ainong Zhou; Rosine Djokam; Simon Metenou; Rose G F Leke; Diane Wallace Taylor
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

8.  Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities.

Authors:  Danica A Helb; Kevin K A Tetteh; Philip L Felgner; Jeff Skinner; Alan Hubbard; Emmanuel Arinaitwe; Harriet Mayanja-Kizza; Isaac Ssewanyana; Moses R Kamya; James G Beeson; Jordan Tappero; David L Smith; Peter D Crompton; Philip J Rosenthal; Grant Dorsey; Christopher J Drakeley; Bryan Greenhouse
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-27       Impact factor: 11.205

9.  Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific.

Authors:  Onome J Akpogheneta; Nancy O Duah; Kevin K A Tetteh; Samuel Dunyo; David E Lanar; Margaret Pinder; David J Conway
Journal:  Infect Immun       Date:  2008-01-22       Impact factor: 3.441

10.  IL4 gene polymorphism and previous malaria experiences manipulate anti-Plasmodium falciparum antibody isotype profiles in complicated and uncomplicated malaria.

Authors:  Piyatida Tangteerawatana; Hedvig Perlmann; Masashi Hayano; Thareerat Kalambaheti; Marita Troye-Blomberg; Srisin Khusmith
Journal:  Malar J       Date:  2009-12-10       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.